Crossmark

Immune checkpoint inhibitor-induced inflammatory arthritis: a qualitative study identifying unmet patient needs and care gaps

Published Online: 2020-08-01

Published Print: 2020-12

Authors

Cappelli, Laura C. http://orcid.org/0000-0003-2795-7059
Grieb, Suzanne M.

Shah, Ami A.

Bingham, Clifton O. III

Orbai, Ana-Maria
License Information

Text and Data Mining valid from 2020-08-01

Version of Record valid from 2020-08-01
More Information

Article History

Received: 21 January 2020

Accepted: 14 April 2020

First Online: 1 August 2020

Ethics approval and consent to participate

: The study was IRB approved and all patients signed informed consent to participate.

: N/A

: LCC: BMS research funding. COB: BMS advisory board, research funding, Consultant: BMS, Genentech/Roche, Sanofi/Regeneron.

Document is current